Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.34 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.33 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.33 |
| ▸ | TSPO | P30536 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | RAC2 | P15153 | 1/20 | 0.30 |
| ▸ | RAC3 | P60763 | 1/20 | 0.30 |
| ▸ | CDC42 | P60953 | 1/20 | 0.30 |
| ▸ | RAC1 | P63000 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19444806 | 0.97 | KDM4E (0.43) | KDM4EATML3MBTL1PTGER4AKR1C4 | |
| SCHEMBL25693709 | 0.93 | KDM4E (0.42) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL21865921 | 0.91 | KDM4E (0.33) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL25757321 | 0.90 | KDM4E (0.41) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL19509854 | 0.88 | KDM4E (0.46) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL20698444 | 0.87 | KDM4E (0.45) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL23546586 | 0.86 | KDM4E (0.34) | KDM4EATML3MBTL1PTGER4AKR1C4 | |
| SCHEMBL26704885 | 0.86 | KDM4E (0.32) | KDM4EATML3MBTL1TSPO | |
| SCHEMBL12909044 | 0.86 | KDM4E (0.41) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL22145914 | 0.86 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190280211-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2019-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190280211-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | ALDH1A2, AOX1, AOC3 | KDM4E 3831/4885ATM 3338/4885L3MBTL1 4131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.